Cargando…
Health technology assessment and price negotiation alignment for rare disorder drugs in Canada: Who benefits?
BACKGROUND: Since 2014, the Canadian Agency for Drugs and Technologies in Health (CADTH), which performs health technology assessments for all federal, provincial and territorial government drug programs (except Quebec’s) and the pan-Canadian Pharmaceutical Alliance (pCPA), which conducts price nego...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190095/ https://www.ncbi.nlm.nih.gov/pubmed/35698235 http://dx.doi.org/10.1186/s13023-022-02390-x |